Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.53
-0.30 (-4.39%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Verrica Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 30.15 | 46.33 | 69.55 | 34.27 | 15.75 | Upgrade
|
| Short-Term Investments | - | - | - | - | 54.6 | Upgrade
|
| Cash & Short-Term Investments | 30.15 | 46.33 | 69.55 | 34.27 | 70.35 | Upgrade
|
| Cash Growth | -34.93% | -33.38% | 102.92% | -51.29% | 7.46% | Upgrade
|
| Receivables | 5.4 | 0.08 | 4.42 | 0.49 | - | Upgrade
|
| Inventory | 2.24 | 2.46 | 1.02 | - | - | Upgrade
|
| Prepaid Expenses | 2.8 | 2.31 | 2.55 | 4.36 | 3.97 | Upgrade
|
| Other Current Assets | 1.96 | - | - | - | - | Upgrade
|
| Total Current Assets | 42.54 | 51.18 | 77.53 | 39.12 | 74.33 | Upgrade
|
| Property, Plant & Equipment | 1.86 | 2.58 | 3.62 | 5.33 | 5.5 | Upgrade
|
| Other Long-Term Assets | 2.73 | 0.38 | 0.45 | 0.28 | 0.3 | Upgrade
|
| Total Assets | 47.13 | 54.13 | 81.6 | 44.72 | 80.13 | Upgrade
|
| Accounts Payable | 2.07 | 1.9 | 2.46 | 0.51 | 0.85 | Upgrade
|
| Accrued Expenses | 4.03 | 3.09 | 8.17 | 2.43 | 3.01 | Upgrade
|
| Short-Term Debt | - | - | - | - | 41.69 | Upgrade
|
| Current Portion of Long-Term Debt | - | 12.94 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.75 | 0.67 | 0.7 | 0.3 | 0.25 | Upgrade
|
| Current Unearned Revenue | 0.78 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 8.81 | 10.42 | 5.69 | 0.22 | 0.26 | Upgrade
|
| Total Current Liabilities | 16.44 | 29.01 | 17.02 | 3.46 | 46.06 | Upgrade
|
| Long-Term Debt | - | 30.98 | 42.87 | - | - | Upgrade
|
| Long-Term Leases | 0.89 | 1.35 | 1.94 | 1.23 | 1.47 | Upgrade
|
| Other Long-Term Liabilities | 5.07 | 2.65 | - | - | - | Upgrade
|
| Total Liabilities | 22.39 | 63.99 | 61.83 | 4.69 | 47.52 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 349.65 | 297.17 | 250.21 | 203.48 | 171.6 | Upgrade
|
| Retained Earnings | -324.91 | -307.03 | -230.45 | -163.45 | -138.97 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0.03 | Upgrade
|
| Total Common Equity | 24.74 | -9.86 | 19.76 | 40.03 | 32.61 | Upgrade
|
| Shareholders' Equity | 24.74 | -9.86 | 19.76 | 40.03 | 32.61 | Upgrade
|
| Total Liabilities & Equity | 47.13 | 54.13 | 81.6 | 44.72 | 80.13 | Upgrade
|
| Total Debt | 1.63 | 45.94 | 45.51 | 1.53 | 43.41 | Upgrade
|
| Net Cash (Debt) | 28.52 | 0.39 | 24.04 | 32.75 | 26.95 | Upgrade
|
| Net Cash Growth | 7211.79% | -98.38% | -26.60% | 21.53% | -4.67% | Upgrade
|
| Net Cash Per Share | 2.68 | 0.08 | 5.30 | 9.59 | 9.96 | Upgrade
|
| Filing Date Shares Outstanding | 17.18 | 9.18 | 4.24 | 4.19 | 2.75 | Upgrade
|
| Total Common Shares Outstanding | 17.18 | 9.18 | 4.24 | 4.11 | 2.75 | Upgrade
|
| Working Capital | 26.1 | 22.17 | 60.51 | 35.66 | 28.27 | Upgrade
|
| Book Value Per Share | 1.44 | -1.07 | 4.66 | 9.74 | 11.85 | Upgrade
|
| Tangible Book Value | 24.74 | -9.86 | 19.76 | 40.03 | 32.61 | Upgrade
|
| Tangible Book Value Per Share | 1.44 | -1.07 | 4.66 | 9.74 | 11.85 | Upgrade
|
| Machinery | 1.21 | 1.79 | 2.17 | 2 | 1.37 | Upgrade
|
| Construction In Progress | - | - | - | 2.54 | 2.73 | Upgrade
|
| Leasehold Improvements | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.